BioStem Technologies Reports Breakthrough Results with AmnioWrap2® in Retrospective Wound Care Study
26 juin 2024 08h30 HE
|
Biostem Technologies
BioStem Technologies Reports Breakthrough Results with AmnioWrap2® in Retrospective Wound Care Study
UPDATE -- PRISM MarketView Showcases BioStem Technologies: Impressive Revenue Growth and Strategic Expansion
17 juin 2024 14h07 HE
|
PRISM MarketView
PRISM MarketView Showcases BioStem Technologies: Impressive Revenue Growth and Strategic Expansion
PRISM MarketView Showcases BioStem Technologies: Impressive Revenue Growth and Strategic Expansion
17 juin 2024 10h17 HE
|
PRISM MarketView
PRISM MarketView Showcases BioStem Technologies: Impressive Revenue Growth and Strategic Expansion
BioStem Technologies to Sponsor MRO Better Half Dash
29 mai 2024 11h00 HE
|
Biostem Technologies
BioStem Technologies to Sponsor MRO Better Half Dash
BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million
14 mai 2024 16h01 HE
|
Biostem Technologies
BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million
BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
07 mai 2024 08h00 HE
|
Biostem Technologies
BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
BioStem Technologies Granted Prioritized Examination for Wound Healing Patent
06 mai 2024 08h00 HE
|
Biostem Technologies
BioStem Technologies Granted Prioritized Examination for Wound Healing Patent
BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts
30 avr. 2024 08h30 HE
|
Biostem Technologies
BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts
BioStem Technologies to Present at the 2024 Planet MicroCap Showcase
25 avr. 2024 08h00 HE
|
Biostem Technologies
BioStem Technologies to Present at the 2024 Planet MicroCap Showcase
BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange
24 avr. 2024 08h00 HE
|
Biostem Technologies
BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange